You cannot register for this webinar

Synthetic biology is surging toward an impressive expansion—many are projecting growth from $19B in 2024 to $62B by 2029. This explosive growth is underpinned by a broad range of core products (from synthetic genes to custom production systems) and enabling technologies (including gene editing, DNA sequencing, and bioinformatics), all of which are fueling new opportunities across sectors like healthcare, industrial chemicals, consumer products, and agriculture. Moreover, cutting-edge foundries are now routinely engineering, constructing, and testing designer organisms that are reshaping industries—from creating the perfect blend of flavor, texture, and nutrition in food to optimizing weight, strength, and flexibility in textiles—all while opening up sustainable market possibilities on a global scale. Join us for this live webinar where SynBioBeta’s Founder and CEO, John Cumbers, and Futurity Systems’ CTO & Co-Founder, Mark Bünger, will unveil insights from the soon-to-be-released 2025 SynBioBeta Investor Report. They’ll share promising data and trends that are shaping the synthetic biology landscape for 2025—insights you won’t want to miss if you’re looking to stay ahead of the curve in this evolving industry. Register for free to secure your spot, and we’ll send you a link to download the full report as soon as it’s available. This is your chance to gain the critical knowledge you need to thrive in synthetic biology’s next chapter!